Insider · CIK 0001686155
David McClung
Files at BCDA (BioCardia, Inc.). First filing Apr 25, 2025, latest Jul 2, 2025.
David McClung files SEC Form 4 as CFO at BCDA (BioCardia, Inc.). Since Apr 25, 2025, David McClung has reported 2 open-market buys worth $35k and 0 open-market sells worth $0, the latest filed on Jul 2, 2025.
A track record needs three past buys with six months of prices behind them; David McClung has 0, so none is measured yet.
The newest scored trade: bought $9,999 of BCDA on Jun 30, 2025, filed Jul 2, 2025, scored 53 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BCDA: BioCardia, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | BioCardia, Inc. | $9,999 4,819 shares | +11% | +11% from low-38% from high | |
| 61Notable | BioCardia, Inc. | $25k 13,123 shares | +44% | +6% from low-40% from high |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | BCDA BioCardia, Inc. | AGrant or award Common Stock | +58,276 | $1.37 | $80k | 106,226 | Dec 10, 2025 |
| Dec 8, 2025 | BCDA BioCardia, Inc. | FTax withholding Common Stock | +29,339 | $1.37 | $40k | 76,887 | Dec 10, 2025 |
| Dec 8, 2025 | BCDA BioCardia, Inc. | AGrant or award Stock Option (right to buy)derivative | +27,000 | $0.00 | $0 | 46,340 | Dec 10, 2025 |
| Jun 30, 2025 | BCDA BioCardia, Inc. | POpen-market purchase Common Stock | +4,819 | $2.08 | $9,999 | 47,950 | Jul 2, 2025 |
| Jun 30, 2025 | BCDA BioCardia, Inc. | POpen-market purchase Warrant (right to buy)derivative | +4,819 | - | - | 26,275 | Jul 2, 2025 |
| Apr 23, 2025 | BCDA BioCardia, Inc. | POpen-market purchase Common Stock | +13,123 | $1.91 | $25k | 43,131 | Apr 25, 2025 |
| Apr 23, 2025 | BCDA BioCardia, Inc. | POpen-market purchase Warrant (right to buy)derivative | +13,123 | - | - | 21,456 | Apr 25, 2025 |
| Oct 11, 2024 | BCDA BioCardia, Inc. | AGrant or award Common Stock | +24,193 | $2.65 | $64k | 41,573 | Oct 16, 2024 |
| Oct 11, 2024 | BCDA BioCardia, Inc. | FTax withholding Common Stock | -11,565 | $2.65 | $31k | 30,008 | Oct 16, 2024 |
Questions about David McClung
Answered from the filings on this page, as of the latest one.
Is David McClung buying or selling?
Not in the last 12 months. David McClung's latest open-market trade on SEC Form 4 was bought $9,999 of BCDA on Jun 30, 2025.
How did David McClung's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David McClung has 0.
Where does David McClung file Form 4?
David McClung has filed Form 4 at BCDA (BioCardia, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.